Lab-free testing moves closer to home as Germany’s Intu Diagnostics raises €1.1 million
Germany's Intu Diagnostics has secured €1.1 million in a strategic bridge funding round, bringing its total investment to over €3 million. This development is significant as it pushes the frontier of decentralized diagnostics, aiming to bring sophisticated molecular testing directly to patients, bypassing traditional laboratory infrastructure. The funding will bolster the company's intellectual property, enable pilot manufacturing trials, and prepare for its upcoming Seed round. The core innovation by Intu Diagnostics lies in its "LAB-TO-GO" platform, which offers doctor's office-level reliability in a compact, power-free device. This technology democratizes access to molecular diagnostics, particularly for infectious diseases, by eliminating the need for specialized equipment, laboratory facilities, or continuous power supply. The company's initial focus is on HPV testing for women's health, with the platform designed for broader adaptability to other infectious diseases, fostering a new era of accessible healthcare. This funding round positions Intu Diagnostics within a burgeoning European HealthTech landscape, with related funding in diagnostics, molecular pathology, and biosensing reaching approximately €84 million in 2026. The startup's ability to deliver lab-free, high-quality testing reflects a broader trend in digital health innovation, promoting European digital sovereignty by developing solutions independent of large, established tech infrastructure. The company’s progress, including IP strengthening and manufacturing trials, underscores its readiness for scaled deployment and its potential impact on global health accessibility.
Curated and translated by Europe Digital for our multilingual European audience.
Why this matters for European digital sovereignty
Germany's Intu Diagnostics secured €1.1 million to advance its decentralized diagnostic platform, a move that enhances European digital sovereignty by developing independent healthtech solutions. This funding supports the company's goal of making sophisticated molecular testing accessible, aligning with a growing European HealthTech ecosystem. The innovation reflects a trend toward European-led digital health advancements.
Source Information
European Alternatives You Might Like
Mangopay
Mangopay is a payment infrastructure provider specializing in payments for marketplaces and platforms. It offers virtual wallet technology for managing funds, enabling features such as split payments, multi-currency support, and KYC/AML compliance. Key functionalities include automated payouts, transaction monitoring, and customizable payment flows. This service is primarily aimed at businesses that manage marketplaces, crowdfunding platforms, and sharing economy models and require complex payment solutions. Mangopay distinguishes itself by offering a flexible and scalable payment solution specifically designed for platform-based business models, allowing them to control cash flows and streamline payment processes.
Scaleway
Scaleway is a European cloud computing provider offering a range of services, including servers, storage, and networking solutions. Key features include bare metal servers, virtual machines, object storage, and managed Kubernetes. It's suitable for developers, startups, and businesses seeking cloud infrastructure for web applications, data storage, and various other workloads. Scaleway distinguishes itself through competitive pricing and a focus on European data sovereignty, with data centers in France and the Netherlands.